Sweden and EU
- Lobsor´ s near-term focus is to obtain market authorization in the Nordic countries and key markets in Europe.
- Lecigon®, has been granted marketing authorization by the Swedish Medical Agency by Oct 5th 2018. Process of obtaining pricing and reimbursement approval in Sweden is ongoing.
US and Canada
- A newly formed US based company, Intrance Medical Systems Inc. is responsible for development and commercialization of Lecigon in the US and Canada.